Laboratory study demonstrates that citral-loaded nanosystems suppress metastasis in colorectal cancer, indicating promising therapeutic potential.
These findings highlight the therapeutic potential of CIT-SNEDDS for enhancing the efficacy of citral as an anti-tumor and antimetastatic agent for colorectal cancer, warranting further in vivo and preclinical studies to optimize its application.
No takes yet. Share an insight, caveat, or question.
Izham et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: